title: Effect of pretreatment with pyridostigmine on the thyrotropin response to thyrotropin-releasing hormone in patients with Cushing's disease.
authors.affiliation: Cattedra di Clinica Medica, University of Brescia, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Giustina
authors.forename: S
authors.initials: S
authors.lastname: Bossoni
authors.forename: M G
authors.initials: MG
authors.lastname: Buffoli
authors.forename: C
authors.initials: C
authors.lastname: Ferrari
authors.forename: A
authors.initials: A
authors.lastname: Pozzi
authors.forename: T
authors.initials: T
authors.lastname: Scalvini
authors.forename: M
authors.initials: M
authors.lastname: Schettino
mesh_terms: D000236:Adenoma / Q000097:blood; D000328:Adult; D003480:Cushing Syndrome / Q000097:blood*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000097:blood; D011729:Pyridostigmine Bromide / Q000494:pharmacology*; D011863:Radioimmunoassay; D013972:Thyrotropin / Q000097:blood*; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology*
chemical_list: D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D011729:Pyridostigmine Bromide